PCLAF and neoplasm: This compensatory proliferation is an evolutionarily conserved process involved in tissue regeneration in lower animals, and is thought to occur with tumor cells treated with cytotoxic radiotherapy, as previously discussed.1 The alkyl- acyl-glycerophosphocholine (GPC), platelet-activating factor (PAF), binds to the PAF receptor.